DAFNA Capital Management as of June 30, 2024
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 83 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p Biotech Etf Etf (XBI) | 9.9 | $41M | 445k | 92.71 | |
| Stereotaxis Com New (STXS) | 5.9 | $25M | 14M | 1.82 | |
| Merus N V (MRUS) | 5.8 | $24M | 409k | 59.17 | |
| Cytokinetics Com New (CYTK) | 5.2 | $22M | 398k | 54.18 | |
| Revolution Medicines (RVMD) | 4.7 | $20M | 512k | 38.81 | |
| Ideaya Biosciences (IDYA) | 3.5 | $15M | 422k | 35.11 | |
| AtriCure (ATRC) | 3.5 | $15M | 639k | 22.77 | |
| Ishares Nasdaq Biotech Indx Etf (IBB) | 3.4 | $14M | 103k | 137.26 | |
| Syndax Pharmaceuticals (SNDX) | 3.2 | $14M | 657k | 20.53 | |
| Blueprint Medicines (BPMC) | 2.7 | $11M | 105k | 107.78 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 2.6 | $11M | 81k | 136.38 | |
| Xenon Pharmaceuticals (XENE) | 2.5 | $11M | 274k | 38.99 | |
| Viking Therapeutics (VKTX) | 2.4 | $10M | 189k | 53.01 | |
| Neurocrine Biosciences (NBIX) | 2.4 | $9.9M | 72k | 137.67 | |
| Kalvista Pharmaceuticals (KALV) | 2.3 | $9.5M | 807k | 11.78 | |
| Day One Biopharmaceuticals I (DAWN) | 2.2 | $9.2M | 667k | 13.78 | |
| Kura Oncology (KURA) | 2.1 | $8.7M | 424k | 20.59 | |
| Tandem Diabetes Care Com New (TNDM) | 2.0 | $8.2M | 204k | 40.29 | |
| Morphic Hldg (MORF) | 1.9 | $7.9M | 232k | 34.07 | |
| Urogen Pharma (URGN) | 1.9 | $7.9M | 469k | 16.78 | |
| Biohaven (BHVN) | 1.8 | $7.6M | 219k | 34.71 | |
| Dex (DXCM) | 1.8 | $7.4M | 66k | 113.38 | |
| Axogen (AXGN) | 1.6 | $6.8M | 936k | 7.24 | |
| Edgewise Therapeutics (EWTX) | 1.2 | $5.2M | 290k | 18.01 | |
| Larimar Therapeutics (LRMR) | 1.1 | $4.6M | 640k | 7.25 | |
| Ascendis Pharma A/s Note 2.250% 4/0 (Principal) | 1.1 | $4.4M | 4.0M | 1.10 | |
| BioCryst Pharmaceuticals (BCRX) | 1.0 | $4.4M | 705k | 6.18 | |
| Century Therapeutics (IPSC) | 1.0 | $4.3M | 1.7M | 2.55 | |
| Alector (ALEC) | 1.0 | $4.1M | 913k | 4.54 | |
| 2seventy Bio Common Stock (TSVT) | 1.0 | $4.0M | 1.1M | 3.85 | |
| Arcus Biosciences Incorporated (RCUS) | 0.9 | $3.9M | 253k | 15.23 | |
| Galapagos Nv Spon Adr (GLPG) | 0.8 | $3.2M | 130k | 24.78 | |
| Insulet Corporation (PODD) | 0.8 | $3.2M | 16k | 201.80 | |
| Keros Therapeutics (KROS) | 0.7 | $3.1M | 68k | 45.70 | |
| Acelyrin (SLRN) | 0.7 | $3.1M | 694k | 4.41 | |
| Alkermes SHS (ALKS) | 0.7 | $2.9M | 121k | 24.10 | |
| Stoke Therapeutics (STOK) | 0.7 | $2.8M | 207k | 13.51 | |
| Astria Therapeutics (ATXS) | 0.6 | $2.5M | 274k | 9.10 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.6 | $2.5M | 122k | 20.24 | |
| Perspective Therapeutics Com New (CATX) | 0.6 | $2.3M | 232k | 9.97 | |
| Accuray Incorporated (ARAY) | 0.5 | $2.2M | 1.2M | 1.82 | |
| Iteos Therapeutics (ITOS) | 0.5 | $2.1M | 144k | 14.84 | |
| Silverback Therapeutics (SPRY) | 0.5 | $2.0M | 239k | 8.51 | |
| Mediwound Shs New (MDWD) | 0.5 | $1.9M | 125k | 15.52 | |
| Brainsway Sponsored Ads (BWAY) | 0.4 | $1.8M | 298k | 6.07 | |
| Inogen (INGN) | 0.4 | $1.7M | 209k | 8.13 | |
| Immatics Nv SHS (IMTX) | 0.4 | $1.7M | 145k | 11.62 | |
| Regulus Therapeutics (RGLS) | 0.4 | $1.6M | 895k | 1.78 | |
| Proqr Therapeutics N V Shs Euro (PRQR) | 0.4 | $1.5M | 906k | 1.66 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.4 | $1.5M | 243k | 6.04 | |
| Allogene Therapeutics (ALLO) | 0.3 | $1.4M | 605k | 2.33 | |
| Mineralys Therapeutics (MLYS) | 0.3 | $1.4M | 119k | 11.70 | |
| Aquestive Therapeutics (AQST) | 0.3 | $1.4M | 530k | 2.60 | |
| Lineage Cell Therapeutics In (LCTX) | 0.3 | $1.3M | 1.4M | 1.00 | |
| Alto Neuroscience Com Shs (ANRO) | 0.3 | $1.3M | 120k | 10.69 | |
| Gossamer Bio (GOSS) | 0.3 | $1.3M | 1.4M | 0.90 | |
| Immunovant (IMVT) | 0.3 | $1.3M | 48k | 26.40 | |
| Sage Therapeutics (SAGE) | 0.3 | $1.3M | 116k | 10.86 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.3 | $1.2M | 347k | 3.48 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.3 | $1.1M | 123k | 9.03 | |
| Tourmaline Bio (TRML) | 0.2 | $977k | 76k | 12.86 | |
| Sutro Biopharma (STRO) | 0.2 | $966k | 330k | 2.93 | |
| Procept Biorobotics Corp (PRCT) | 0.2 | $855k | 14k | 61.09 | |
| Polypid (PYPD) | 0.2 | $795k | 185k | 4.30 | |
| Compugen Ord (CGEN) | 0.2 | $777k | 462k | 1.68 | |
| Nyxoah S A SHS (NYXH) | 0.2 | $754k | 108k | 6.97 | |
| Adicet Bio (ACET) | 0.2 | $726k | 600k | 1.21 | |
| Acrivon Therapeutics Common Stock (ACRV) | 0.2 | $704k | 121k | 5.80 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.2 | $701k | 136k | 5.16 | |
| Adc Therapeutics Sa SHS (ADCT) | 0.2 | $645k | 204k | 3.16 | |
| Terns Pharmaceuticals (TERN) | 0.1 | $586k | 86k | 6.81 | |
| Neuronetics (STIM) | 0.1 | $565k | 314k | 1.80 | |
| Aprea Therapeutics Com New (APRE) | 0.1 | $558k | 137k | 4.07 | |
| Neurogene (NGNE) | 0.1 | $400k | 11k | 36.39 | |
| Masimo Corporation (MASI) | 0.1 | $378k | 3.0k | 125.94 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.1 | $333k | 341k | 0.97 | |
| Oric Pharmaceuticals (ORIC) | 0.1 | $255k | 36k | 7.07 | |
| Foghorn Therapeutics (FHTX) | 0.1 | $241k | 42k | 5.75 | |
| Nevro (NVRO) | 0.1 | $236k | 28k | 8.42 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.0 | $196k | 5.0k | 39.27 | |
| Karyopharm Therapeutics (KPTI) | 0.0 | $167k | 193k | 0.87 | |
| Spero Therapeutics (SPRO) | 0.0 | $163k | 125k | 1.30 | |
| Compass Therapeutics (CMPX) | 0.0 | $117k | 117k | 1.00 |
